Tolerability, Acceptance, and Utility of Intermittent CGM Use in Youth With Prediabetes

NACompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

June 5, 2023

Primary Completion Date

May 15, 2025

Study Completion Date

May 15, 2025

Conditions
PreDiabetesObesityInsulin Resistance
Interventions
DEVICE

Abbott Freestyle Libre 2

Subjects will be educated on use of Abbott Freestyle Libre 2 and educated on how daily activities impact glucose.

OTHER

Standard physical activity and nutritional counseling for prediabetes management

Subjects will be advised on recommendations for nutrition and activity goals for preventing progression of prediabetes.

Trial Locations (1)

35233

Children's of Alabama, Birmingham

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

University of Alabama at Birmingham

OTHER

NCT05505565 - Tolerability, Acceptance, and Utility of Intermittent CGM Use in Youth With Prediabetes | Biotech Hunter | Biotech Hunter